Morgan Stanley’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,831
| Closed | -$396 | – | 8016 |
|
|
2024
Q1 | $396 | Sell |
2,831
-2,834
| -50% | -$396 | ﹤0.01% | 7261 |
|
|
2023
Q4 | $824 | Buy |
5,665
+2,831
| +100% | +$412 | ﹤0.01% | 7227 |
|
|
2023
Q3 | $497 | Sell |
2,834
-3,512
| -55% | -$616 | ﹤0.01% | 7307 |
|
|
2023
Q2 | $19.8K | Sell |
6,346
-50,789
| -89% | -$158K | ﹤0.01% | 6574 |
|
|
2023
Q1 | $146K | Buy |
57,135
+56,744
| +14,513% | +$145K | ﹤0.01% | 5845 |
|
|
2022
Q4 | $582 | Sell |
391
-691
| -64% | -$1.03K | ﹤0.01% | 7539 |
|
|
2022
Q3 | $2K | Sell |
1,082
-3,025
| -74% | -$5.59K | ﹤0.01% | 7504 |
|
|
2022
Q2 | $6K | Sell |
4,107
-1,441
| -26% | -$2.11K | ﹤0.01% | 7374 |
|
|
2022
Q1 | $13K | Sell |
5,548
-184,968
| -97% | -$433K | ﹤0.01% | 7323 |
|
|
2021
Q4 | $874K | Buy |
190,516
+184,908
| +3,297% | +$848K | ﹤0.01% | 5169 |
|
|
2021
Q3 | $45K | Sell |
5,608
-293
| -5% | -$2.35K | ﹤0.01% | 6774 |
|
|
2021
Q2 | $57K | Sell |
5,901
-6,406
| -52% | -$61.9K | ﹤0.01% | 6617 |
|
|
2021
Q1 | $108K | Sell |
12,307
-3,680
| -23% | -$32.3K | ﹤0.01% | 5967 |
|
|
2020
Q4 | $164K | Buy |
15,987
+13,210
| +476% | +$136K | ﹤0.01% | 5686 |
|
|
2020
Q3 | $25K | Sell |
2,777
-3,016
| -52% | -$27.2K | ﹤0.01% | 5983 |
|
|
2020
Q2 | $41K | Buy |
5,793
+1,046
| +22% | +$7.4K | ﹤0.01% | 5747 |
|
|
2020
Q1 | $45K | Buy |
4,747
+2,391
| +101% | +$22.7K | ﹤0.01% | 5504 |
|
|
2019
Q4 | $31K | Buy |
+2,356
| New | +$31K | ﹤0.01% | 5992 |
|